Organ dysfunction among piglets treated with inhaled nitric oxide and intravenous hydrocortisone during prolonged endotoxin infusion

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Göranson, Sofie Paues ^a   Goździk, Waldemar ^b   Harbut, Piotr ^a   Ryniak, Stanisław ^a   Zielinski, Stanisław ^b   Haegerstrand, Caroline Gillis ^a   Kübler, Andrzej ^b   Hedenstierna, Göran ^c   Frostell, Claes ^a   Albert, Johanna ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ENDOTOXIN; HYDROCORTISONE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROTECTIVE AGENT;

ACIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENDOTOXEMIA; HEART PROTECTION; INFLAMMATION; KIDNEY DYSFUNCTION; LOADING DRUG DOSE; LUNG ARTERY PRESSURE; MEAN ARTERIAL PRESSURE; MULTIPLE ORGAN FAILURE; NONHUMAN; ORGAN INJURY; PIGLET; PORCINE MODEL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; SURVIVAL RATE; TOXICITY TESTING; ANIMAL; BLOOD; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; HEMODYNAMICS; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; KIDNEY FUNCTION TEST; METABOLISM; PATHOPHYSIOLOGY; SWINE; TIME;

ADMINISTRATION, INHALATION; ANIMALS; CREATININE; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; HEMODYNAMICS; HYDROCORTISONE; INJECTIONS, INTRAVENOUS; KIDNEY; KIDNEY FUNCTION TESTS; LIPOPOLYSACCHARIDES; NITRIC OXIDE; PROTECTIVE AGENTS; SWINE; TIME FACTORS;

EID: 84901301695     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096594     Document Type: Article

References (29)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310. (Pubitemid 32641789)
2. Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546-1554. (Pubitemid 36437931)
3. Brun-Buisson C, Meshaka P, Pinton P, Vallet B, EPISEPSIS Study Group (2004) EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 30: 580-588. (Pubitemid 38530092)
4. Winters BD, Eberlein M, Leung J, Needham DM, Pronovost PJ, et al. (2010) Long-term mortality and quality of life in sepsis:A systematic review. Crit Care Med 38: 1276-1283.
5. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM (1991) Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83: 2038-2047.
6. Rossaint R, Pison U, Gerlach H, Falke KJ (1993) Inhaled nitric oxide: its effects on pulmonary circulation and airway smooth muscle cells. Eur Heart J: 14 Suppl I: 133-140. (Pubitemid 23362606)
7. Mathru M, Huda R, Solanki DR, Hays S, Lang JD, et al. (2007) Inhaled nitric oxide attenuates reperfusion inflammatory responses in humans. Anesthesiology 106:275-282. (Pubitemid 46185172)
8. Gozdzik W, Albert J, Harbut P, Zieliński S, Ryniak S, et al. (2009) Prolonged exposure to inhaled nitric oxide transiently modifies tubular function in healthy piglets and promotes tubular apoptosis. ActaPhysiol (Oxf) 195: 495-502.
9. Evans MJ, Stephens RJ, Cabral LJ, Freeman G (1972) Cell renewal in the lungs of rats exposed to low levels of NO2. Arch Environ Health 24:180-188.
10. Krafft P, Fridrich P, Fitzgerald RD, Koc D, Steltzer H (1996) Effectiveness of nitric oxide inhalation in septic ARDS. Chest 109:486-493. (Pubitemid 26058610)
11. Kinsella JP, Parker TA, Galan H, Sheridan BC, Halbower AC, et al. (1997) Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res 41:457-463. (Pubitemid 27147859)
12. Bogdan C, Rollinghoff M, Diefenbach A (2000) The role of nitric oxide in innate immunity. Immunol Rev 173: 17-26. (Pubitemid 30095207)
13. Weitzberg E, Hezel M, Lundberg JO (2010) Nitrate-nitrite-nitric oxide pathway: implications for anesthesiology and intensive care. Anesthesiology 113: 1460-1475.
14. Kang JL, Park W, Pack IS, Lee HS, Kim MJ, et al. (2002) Inhaled nitric oxide attenuates acute lung injury via inhibition of nuclear factor-kappa B and inflammation. J ApplPhysiol 92:795-801. (Pubitemid 34671050)
15. Phillips L, Toledo AH, Lopez-Neblina F, Anaya-Prado R, Toledo-Pereyra LH (2009) Nitric oxide mechanism of protection in ischemia and reperfusion injury. J Invest Surg 22: 46-55.
16. Chadda K, Annane D (2002) The use of corticosteroids in severe sepsis and acute respiratory distress syndrome. Ann Med 34: 582-589. (Pubitemid 36113817)
17. Yang S, Zhang L (2004) Glucocorticoids and vascular reactivity. CurrVascPharmacol 2: 1-12. (Pubitemid 38855010)
18. Da J, Chen L, Hedenstierna G (2007) Nitric oxide up-regulates the glucocorticoid receptor and blunts the inflammatory reaction in porcine endotoxin sepsis. Crit Care Med 35: 26-32. (Pubitemid 46035673)
19. Albert J, Harbut P, Zielinski S, Ryniak S, Gillis-Haegerstrand C, et al. (2007) Prolonged exposure to inhaled nitric oxide does not affect haemostasis in piglets. Intensive Care Med 33: 1594-1601. (Pubitemid 47312461)
20. Wang HM, Bodenstein M, Markstaller K (2008) Overview of the pathology of three widely used animal models of acute lung injury. Eur Surg Res; 40: 305-316. (Pubitemid 351704903)
21. Poli-de-Figueiredo LF, Garrido AG, Nakagawa N, Sannomiya P (2008) Experimental models of sepsis and their clinical relevance. Shock Oct 30, Suppl 1: 53-59.
22. Persson BP, Boels PJ, Lövdahl C, Rossi P, Oldner A (2011) Endotoxin induces differentiated contractile responses in porcine pulmonary arteries and veins. J Vasc Res. 48(3): 206-218.
23. Bellomo R, Kellum JA, Ronco C (2007) Defining and classifying acute renal failure: from advocay to consensus and validation of the RIFLE criteria. Intensive Care Med 33: 409-413. (Pubitemid 46333828)
24. Ostermann M, Chang RWS (2007) Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 35: 1837-1843. (Pubitemid 47220356)
25. Hållström L, Berghäll E, Frostell C, Sollevi A, Soop AL (2011) Immunomodulation by a combination of nitric oxide and glucocorticoids in a human endotoxin model. Acta Anaesthesiol Scand 55: 20-27.
26. Hållström L, Berghäll E, Frostell C, Sollevi A, Soop AL (2008) Nitric oxide inhalation and glucocorticoids as combined treatment in human experimental endotoxemia. Crit Care Med 36: 3043-3047.
27. Pierrakos C, Vincent JL (2010) Sepsis biomarkers: a review. Crit Care 14: R 15.
28. Rivers EP, Jaehne AK, Nguyen HB, Papamatheakis DG, Singer D, et al. (2013) Early biomarker activity in severe sepsis and septic shock and a contemporary review of immunotherapy trials: not a time to give up, but to give it earlier. Shock 39: 127-137.
29. Gozdzik W, Olbromski M, Harbut P, Zielinski S, Ratajczak K, et al. (2012) Inhaled nitric oxide combined with corticosteroids attenuate kidney and heart toll-like receptors 4 expression in a porcine suprarenal aortic cross clamping ischemia reperfusion model. Brit J Anaesth 108 suppl.2; s.ii101 .1203.0.